Related Experiment Video
Updated: Jan 26, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
R Elqadiry1, O Louachama1, N Rada1
1Pediatric A Department, Mother-Child Pole, Mohammed VI University Hospital, Marrakesh, Morocco.
Insights
Recurrent Kawasaki disease (KD) is rare but possible in infants. Early diagnosis and treatment with intravenous immunoglobulin (IVIG) are crucial for managing this vasculitis and preventing coronary artery damage.
Area of Science:
- Pediatrics
- Rheumatology
- Infectious Diseases
Background:
- Kawasaki disease (KD) is a vasculitis primarily affecting young children.
- While typical KD diagnosis is straightforward, atypical presentations and recurrences pose diagnostic challenges.
- This case highlights the importance of recognizing recurrent KD in infants.
Observation:
- An infant initially diagnosed with complete Kawasaki disease at 13 months presented with classic symptoms and inflammatory markers.
- The infant received intravenous immunoglobulin (IVIG) and aspirin, showing good initial response with normal echocardiography.
- Seven months later, the same infant experienced a relapse with similar symptoms, leading to a diagnosis of recurrent KD.
Findings:
- The recurrent episode met the American Heart Association criteria for KD.
- Both initial and recurrent episodes were successfully treated with IVIG.
- Echocardiography remained normal throughout both disease episodes, indicating no coronary artery abnormalities.
Implications:
- Clinicians must consider the possibility of recurrent Kawasaki disease, even in infants.
- Prompt recognition and management of recurrent KD are essential for preventing long-term complications, particularly coronary artery lesions.
- This case underscores the variability of KD and the need for vigilance in diagnosis and treatment.
Introduction:
While the diagnosis of typical form of Kawasaki disease (KD) is obvious, this multifaceted disease continues to surprise us. We report the case of a recurrent Kawasaki disease in an infant.
Case:
At the age of 13 months, the infant was diagnosed with complete Kawasaki disease; he presented with prolonged fever, bilateral conjunctivitis, enanthem, exanthema, edema of the lower limb, peeling, and biological inflammatory syndrome. He was treated with intravenous immunoglobulin (IVIG) associated with a high dose of aspirin and then an antiplatelet dose with a good clinical-biological evolution. The echocardiography was normal. Seven months later, the patient was again admitted, in a similar picture: a prolonged fever evolving for 7 days, bilateral conjunctivitis, enanthem, cervical adenopathy of 1.5 cm/1 cm, scarlatiniform erythema, pruriginous of the trunk and limb, and peeling of the toes, with indurated edema of the hands and feet. The rest of the examination was normal except the irritability. The diagnosis of recurrent KD was made according the five criteria of the American Heart Association. The echocardiography was normal again. The infant received IVIG with good outcome.
Conclusion:
Despite its rarity, the possibility of recurrence of KD should be known by clinicians, so as not to delay the specific management of vasculitis whose stakes in terms of prevention of coronary artery lesions are well known. Our case confirms the possibility of this recurrence.
More Related Videos
07:11Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug Dosing: Infants and Children
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF